Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael M Hoffmann

Showing results (11-20 of 98) with videos related to

Pageof 10
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|April 30, 2005
Genotype and plasma concentration of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular eventsMichael Loew, Michael M Hoffmann, Wolfgang Koenig, et al.
Vascular Pharmacology|April 2, 2014
Risk prediction with proprotein convertase subtilisin/kexin type 9 (PCSK9) in patients with stable coronary disease on statin treatmentChristian Werner, Michael M Hoffmann, Karl Winkler, et al.
Cardiovascular Diabetology|November 20, 2014
Association of secreted frizzled-related protein 4 (SFRP4) with type 2 diabetes in patients with stable coronary artery diseaseMichael M Hoffmann, Christian Werner, Michael Böhm, et al.
Atherosclerosis|November 26, 2011
Ezetimibe alone and in combination lowers the concentration of small, dense low-density lipoproteins in type 2 diabetes mellitusKarl Winkler, Stephan Jacob, Tina Müller-Schewe, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|June 9, 2005
Smoking, apolipoprotein E genotype, and early onset of coronary heart diseaseMichael Loew, Michael M Hoffmann, Harry Hahmann, et al.
Pancreas|March 23, 2006
Recurrent acute and chronic pancreatitis in two brothers with familial chylomicronemia syndromeKaspar Truninger, Peter A Schmid, Michael M Hoffmann, et al.
European Heart Journal|December 2, 2004
The apolipoprotein E polymorphism is associated with circulating C-reactive protein (the Ludwigshafen risk and cardiovascular health study)Winfried März, Hubert Scharnagl, Michael M Hoffmann, et al.
BMC Cardiovascular Disorders|June 10, 2005
Prognostic value of interleukin-1 receptor antagonist gene polymorphism and cytomegalovirus seroprevalence in patients with coronary artery diseaseDietrich Rothenbacher, Hermann Brenner, Thomas Mertens, et al.
The Journal of Clinical Endocrinology and Metabolism|March 6, 2004
Fluvastatin slow-release lowers platelet-activating factor acetyl hydrolase activity: a placebo-controlled trial in patients with type 2 diabetesKarl Winkler, Claudia Abletshauser, Isolde Friedrich, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|August 24, 2006
Genotype combinations of plasminogen activator inhibitor-1 and angiotensin-converting enzyme genes and risk for early onset of coronary heart diseaseMichael Loew, Michael M Hoffmann, Harry Hahmann, et al.
Pageof 10

Showing results (11-20 of 98) with videos related to

Sort By:
Pageof 10
Arteriosclerosis, Thrombosis, and Vascular Biology|April 30, 2005
Genotype and plasma concentration of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular eventsMichael Loew, Michael M Hoffmann, Wolfgang Koenig, et al.
Vascular Pharmacology|April 2, 2014
Risk prediction with proprotein convertase subtilisin/kexin type 9 (PCSK9) in patients with stable coronary disease on statin treatmentChristian Werner, Michael M Hoffmann, Karl Winkler, et al.
Cardiovascular Diabetology|November 20, 2014
Association of secreted frizzled-related protein 4 (SFRP4) with type 2 diabetes in patients with stable coronary artery diseaseMichael M Hoffmann, Christian Werner, Michael Böhm, et al.
Atherosclerosis|November 26, 2011
Ezetimibe alone and in combination lowers the concentration of small, dense low-density lipoproteins in type 2 diabetes mellitusKarl Winkler, Stephan Jacob, Tina Müller-Schewe, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|June 9, 2005
Smoking, apolipoprotein E genotype, and early onset of coronary heart diseaseMichael Loew, Michael M Hoffmann, Harry Hahmann, et al.
Pancreas|March 23, 2006
Recurrent acute and chronic pancreatitis in two brothers with familial chylomicronemia syndromeKaspar Truninger, Peter A Schmid, Michael M Hoffmann, et al.
European Heart Journal|December 2, 2004
The apolipoprotein E polymorphism is associated with circulating C-reactive protein (the Ludwigshafen risk and cardiovascular health study)Winfried März, Hubert Scharnagl, Michael M Hoffmann, et al.
BMC Cardiovascular Disorders|June 10, 2005
Prognostic value of interleukin-1 receptor antagonist gene polymorphism and cytomegalovirus seroprevalence in patients with coronary artery diseaseDietrich Rothenbacher, Hermann Brenner, Thomas Mertens, et al.
The Journal of Clinical Endocrinology and Metabolism|March 6, 2004
Fluvastatin slow-release lowers platelet-activating factor acetyl hydrolase activity: a placebo-controlled trial in patients with type 2 diabetesKarl Winkler, Claudia Abletshauser, Isolde Friedrich, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|August 24, 2006
Genotype combinations of plasminogen activator inhibitor-1 and angiotensin-converting enzyme genes and risk for early onset of coronary heart diseaseMichael Loew, Michael M Hoffmann, Harry Hahmann, et al.
Pageof 10